Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02312817 · ClinicalTrials.gov registry record · NA
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 1,800
- Enrollment target
NCT02312817: Completed NA study, sponsored by University of Texas Southwestern Medical Center.
NCT02312817 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,800 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02312817, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,800 participants
- Enrollment target
Study Summary
Hepatocellular carcinoma (HCC) is the 9th leading cause of cancer-related death in the US and one of the leading causes of death in patients with cirrhosis. Fewer than 1 in 5 high-risk patients undergo HCC screening, with lower rates in non-Caucasian and low socioeconomic status patients receiving care through safety-net health systems. Screening and follow-up failures lead to more advanced cancers, when curative therapies are not available and survival is significantly worse. Over 60% of HCC are diagnosed at advanced stages, due to poor recognition of high-risk patients, underuse of screening among these patients, and poor follow-up of abnormal screening tests. To address these barriers, the investigators propose to conduct a comparative effectiveness research randomized controlled trial of three screening strategies among a socioeconomically disadvantaged and racially diverse cohort of cirrhotic patients at high risk for developing HCC. Overall, 1800 patients attending Parkland, the Dallas safety-net health system, will be randomized to: * Group 1: Usual care, with visit-based HCC screening per discretion of individual providers * Group 2: Mailed HCC screening invitation outreach to eligible patients (low resource intensity) * Group 3: Mailed HCC screening invitation outreach to eligible patients combined with centralized patient navigation to promote screening completion and follow-up (high resource intensity) Through three specific aims, this effectiveness research randomized controlled trial will: * Aim 1: Engage stakeholders in design and implementation of HCC screening outreach interventions. * Aim 2: Compare the clinical effectiveness and patient acceptability of the intervention strategies to increase completion of one-time and repeat HCC screening. * Aim 3: Evaluate whether intervention effects are moderated by patient sex, race, ethnicity, English proficiency, and connectedness to primary care. The screening intervention strategies combine EMR-enable
Primary Outcome
Defined as the proportion of patients completing HCC screening within 6 months of randomization.
Interventions
- OTHER Mailed Outreach Invitation
- OTHER Mailed Outreach Invitation and Patient Navigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,800 participants |
| Start Date | 2014-12 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT02312817 record still lists
NCT02312817 is an interventional study that assigns participants to a tested intervention. Its 1,800 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% higher).
The record links to 0 conditions, and to 2 interventions - of which Mailed Outreach Invitation is the first listed.
NCT02312817 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02312817 about?
NCT02312817 is a clinical study titled "RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System". Hepatocellular carcinoma (HCC) is the 9th leading cause of cancer-related death in the US and one of the leading causes of death in patients with cirrhosis. Fewer than 1 in 5 high-risk patients undergo HCC screening, with lower rates in non-Caucasian and low socioeconomic status patients receiving c...
What is the current status of trial NCT02312817?
This trial is currently completed. It is a NA study. The enrollment target is 1,800 participants. The study started on 2014-12. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02312817?
The interventions under investigation include: Mailed Outreach Invitation (OTHER), Mailed Outreach Invitation and Patient Navigation (OTHER).
Who is sponsoring clinical trial NCT02312817?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02312817's enrollment target sits among peer trials
1,800 57th of 2000 higher than 1,942 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
- NCT05258656 · 1,800 participants · NA
Childhood Activities Nutrition and Development Oversight
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia